Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Travere Therapeutics, Inc.)"
Count: 20
Selected: 0
NCT05856760A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
NCT05562362Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension
NCT05200871Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)
NCT05003986Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT04270682Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
NCT03762850A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
NCT03493685Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
NCT03406611Pegtibatinase as an Enzyme Therapy for Patients With Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)
NCT03115086The REPLACE Registry for Cholbam® (Cholic Acid)
NCT03041116Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants
NCT02998710Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
NCT02638220Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
NCT01613118Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
NCT01438411Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis
NCT01115582Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis
NCT00007020Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid
NCT05630612ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
NCT04663204A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
NCT03866954Trial of Erythrocyte Encapsulated Thymidine Phosphorylase In Mitochondrial Neurogastrointestinal Encephalomyopathy
NCT05368038ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program